A once-weekly 29-amino-acid dual agonist of the GLP-1 and glucagon receptors (CAS 2259884-03-0), derived from an oxyntomodulin-inspired scaffold. Licensed by Innovent Biologics from Eli Lilly for Chinese rights (also known as IBI362 / LY3305677). Approved by China's NMPA in 2025 for chronic weight management and for glycemic control in type 2 diabetes — the first dual GCG/GLP-1 agonist approved for obesity globally. Not FDA-approved; under continued clinical evaluation outside China by Lilly.
For research purposes only. Not medical advice.
Ruo Bio currently lists Mazdutide at $5.60/mg, the lowest indexed price across 4 tracked research peptide vendors.
Mazdutide ranges from $5.20/mg to $10.43/mg across 5 listings from 4 research peptide vendors, normalized to USD per milligram and refreshed daily.
4 research peptide vendors currently list Mazdutide on PeptideScouter. We track 5 active listings across size and kit variants.
Mazdutide's CAS Registry Number is 2259884-03-0.